The company has applied for two national invention patents (virus inactivation technology, column chromatography purification technology) in the field of antiserum by taking advantage of its own advantages, and has obtained 22 utility model patents; At the same time, three new antiserum varieties have been developed, and their process research and development technology will fill the domestic blank.